Clarivate Plc filed a Form 8-K on November 12, 2026, announcing the expiration and results of cash tender offers by its wholly-owned subsidiary, Clarivate Science Holdings Corporation, for certain of its debt securities.

Key Highlights

  • Tender offer expired: The cash tender offers conducted by Clarivate Science Holdings Corporation for certain debt securities reached expiration on November 12, 2026.
  • Wholly-owned subsidiary: The tender offers were made by Clarivate Science Holdings Corporation, described in the filing as a wholly-owned subsidiary of Clarivate Plc.
  • Results announced: Clarivate Plc issued a press release on November 12, 2026, disclosing the expiration and results of the previously announced tender offers.
  • Exchange listing: Clarivate Plc ordinary shares, no par value, are listed on NYSE:CLVT.
  • Signed by: John Doulamis, Senior Vice President and General Counsel, signed the filing on behalf of Clarivate Plc.

Clarivate Science Holdings Debt Tender Offer: Expiration and Results

According to the Form 8-K filed with the U.S. Securities and Exchange Commission, Clarivate Plc reported that its wholly-owned subsidiary, Clarivate Science Holdings Corporation, completed the expiration of previously announced cash tender offers for certain of its debt securities. The event date reported is November 12, 2026, the same date the filing was submitted.

The filing discloses under Item 8.01 (Other Events) that Clarivate Plc issued a press release on November 12, 2026, covering the expiration and results of these tender offers. That press release is attached to the filing as Exhibit 99.1 and incorporated by reference. The filing does not include the specific terms of the tender offers, the names of the targeted debt securities, or the principal amounts tendered within the body of the 8-K itself.

The registrant, Clarivate Plc, is incorporated in Jersey, Channel Islands, and maintains its principal executive offices at 70 St. Mary Axe, London, EC3A 8BE, United Kingdom. The filing was signed by John Doulamis in his capacity as Senior Vice President and General Counsel.

What Was Disclosed

Clarivate Plc disclosed via Form 8-K the expiration and results of cash tender offers by subsidiary Clarivate Science Holdings Corporation for certain debt securities, with a press release attached as Exhibit 99.1 providing further detail.